FDA Study on Oral Contraception and HIV Risk in Africa

The Food and Drug Administration (FDA) has issued a notice concerning a study investigating the link between oral contraception use and HIV risk in Africa. The notice is identified by docket number FDA-2026-P-2641-0031 and pertains to research conducted within the African continent.

As this is a notice about a study, there are no immediate compliance actions required for regulated entities. However, drug manufacturers and public health authorities involved in or monitoring research related to reproductive health and infectious diseases should be aware of this publication for informational purposes.